Allogeneic hematopoietic cell transplantation (allo-HCT)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic hematopoietic cell transplantation (allo-HCT), covering 2026-01-07 to 2026-01-07. Get the full timeline:
Most recent: Clinical Trial Update: MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis [Phase 2]